Munich, Germany

Michael Glatza

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Glatza. Retrieved from https://idiyas.com/inventor/michael-glatza

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Glatza: Innovator in Stem Cell Research

Introduction: Michael Glatza is an accomplished inventor based in Hamm, Germany. He is affiliated with the Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., where he contributes to groundbreaking research in the field of stem cells. Although he currently holds no granted patents, his work is significant in advancing scientific knowledge and potential medical applications.

Latest Patent Applications: Michael Glatza's notable patent application is titled "Mammalian Neural Plate Border Stem Cells Capable of Forming Neural Tube and Neural Crest Cell Lineages Including Central and Peripheral Neurons." This invention relates to a method for producing mammalian neural plate border stem cells (NPBSCs) through a series of specific culturing processes. The method involves differentiating mammalian pluripotent stem cells and expanding the resulting NPBSCs in a specialized medium. The application highlights the potential use of these cells in medicine, showcasing the innovative approach taken by Glatza in stem cell research.

Conclusion: Michael Glatza's contributions to the field of stem cell research, particularly through his latest patent application, demonstrate his commitment to advancing medical science. His work holds promise for future developments in regenerative medicine and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…